Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 87

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 87
---
 Mr. Lee.               |   |   |     | ​ |

94 | investor.pacira.com

TABLE OF CONTENTS Executive Compensation

| ​ | Calculation of Annual Total Compensation | ​ | ​ | •                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 We determined the median employee’s 2024 annual total compensation to be $233,124, which is the amount that would have been reported for our median employee in the “Total” column of our 2024 Summary Compensation Table if they had been a Named Executive Officer for fiscal 2024.                                                                                                                                                                                                                                                                
 ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 •                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 We determined the CEO’s 2024 annual total compensation to be $15,944,347. Mr. Lee served as the CEO from January 2, 2024 through the end of the year. For the CEO’s annual total compensation, we used the amount reported in the “Total” column for 2024 in the Summary Compensation Table included in this proxy statement. We did not further annualize Mr. Lee’s compensation for purposes of the pay ratio as he was appointed to the CEO position on the second day of 2024, and his compensation already reflects his full-year compensation. 
 ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 See the Summary Compensation Table “Total” column on page 77 of this proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |     | ​ |

The pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC regulations based on our internal records and the methodology described above. The SEC regulations for identifying the median-compensated employee and calculating the pay ratio based on that employee’s annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates.

Pacira BioSciences, Inc. 2025 Proxy Statement | 95

TABLE OF CONTENTS Executive Compensation

| ​ |                                                                                                   | ​ | ​ | PROPOSAL 4 | ​ |
| ​ | Advisory Vote to Approve the Frequency of Future Advisory Votes to Approve Executive Compensation | ​ |   |            |   |

| ​ |     | ​ | ​ | The board unanimously recommends voting for a frequency period of1-YEARfor future advisory votes to approve the compensation of our named executive officers. | ​ |

As required by Section 14A of the Exchange Act, we are asking stockholders to approve, on an advisory basis, the frequency of future advisory votes to approve the compensation of our named executive officers. This proposal is commonly known as a “say on frequency